A Study of Single and Multiple Doses of ALXN1210 in Healthy, Adult Japanese Participants
Clinical trial NCT05288816 · COMPLETED
Trial details
- NCT number
- NCT05288816
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-18
- Primary completion
- 2017-07-05
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.